This fall, the Journal of Clinical Oncology (JCO) presented two special series: “Pediatric Cancer—Progress through Collaboration” and “Head and Neck Cancer: Recent Advances, Changing Epidemiology and Future Directions.”

Pediatric Series

The Pediatric Special Series highlighted collaborative efforts that have contributed to the remarkable progress achieved in advancing survival for patients with pediatric cancers.

The pediatric cancer experience is unique in that it has a high level of clinical trial participation, making it instrumental in establishing effective therapies, characterizing toxicities of therapy, refining treatment approaches, and modifying therapy to prevent adverse treatment-related effects.

This Special Series also features articles on innovative and genomic discoveries that have guided risk-adapted stratification of therapy and the use of targeted therapy in providing real prospects for precision medicine.

The Pediatric Special Series has broad appeal for not only pediatric oncologists, but also for surgical and radiation oncologists, hospitalists, family physicians, pharmacists, and many others.

Head and Neck Series

The Head and Neck Cancer Special Series delivers the latest evidence and recommendations for management of mucosal head and neck, nasopharyngeal, and nonmelanoma cutaneous carcinomas.

In addition, this series provides timely reviews on the following topics:

• The rapidly evolving data on human papillomavirus-associated oropharyngeal cancer
• Significant technologic advances in surgery and radiotherapy
• Improved understanding of the genomics of head and neck cancers
• Exciting prospects of new immunotherapeutic agents
• Insights into the management of late toxicities
• Survivorship and quality-of-life
  issues

The goal of the Head and Neck Cancer Special series is to enhance the understanding of the advances in the biology and treatment of head and neck cancer, with a focus on the areas of greates relevance to practicing clinicians.

This Special Series will appeal to a broad range of readers, including medical, surgical, and radiation oncologists and nurses, radiation therapists, researchers, speech therapists, dieticians, dentists, industry leaders, and epidemiologists.